776 abstracts found.



Results filter



The 2013 George Edelstyn Lecture: The long and the short of radiotherapy fractionation in early breast cancer

Year:

Session type:

John Yarnold1
1The Institute of Cancer Research, London, UK



Should all breast radiotherapy be delivered with intensity modulated radiotherapy (IMRT)?

Year:

Session type:

Charlotte Coles1
1Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK



How can we reduce cardiac risk for women with left breast cancer?

Year:

Session type:

Anna M Kirby1
1The Royal Marsden NHS Foundation Trust, London, UK



The bacteriome and cancer

Year:

Session type:

Elaine Holmes1
1Imperial College London, London, UK



Diet, the microbiome, and colon cancer risk

Year:

Session type:

Stephen O'Keefe1
1University of Pittsburgh, Pittsburgh, USA



Surgical systems oncology: Translational gut microbiome research in colon cancer

Year:

Session type:

James Kinross1
1Imperial College London, London, UK



Illuminating cancer biology with optoacoustic and thermoacoustic imaging

Year:

Session type:

Vasilis Ntziachristos1
1Helmholtz Zentrum München and Technical University Munich, Munich, Germany



Exploring the colorectal cancer microbiome

Year:

Session type:

Julian R Marchesi1
1Cardiff University, Cardiff, UK



Treatment-induced pain in cancer patients

Year:

Session type:

Michael Bennett1
1University of Leeds, Leeds, UK



We need to talk about clonal diversity

Year:

Session type:

Mel Greaves1

1The Institute of Cancer Research, London, UK




Treatment-induced pain in cancer patients

Year:

Session type:

Patrick Dougherty1
1The University of Texas MD Anderson Cancer Center, Houston, USA



Within-tumour diversity as a universal biomarker of prognosis

Year:

Session type:

Trevor Graham1
1Barts Cancer Institute, London, UK



Update on targeted treatments for painful neuropathy

Year:

Session type:

Marie Fallon1
1IGMM Edinburgh Cancer Research Centre



Imaging tumour heterogeneity

Year:

Session type:

Robert J Gillies1
1H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA



Epidemiology and risk factors for persistent pain after breast cancer surgery

Year:

Session type:

Julie Bruce1
1University of Warwick, Coventry, UK



Clinical decision support systems

Year:

Session type:

Willie Hamilton1
1Peninsula College of Medicine and Dentistry, Exeter, UK



Clinical decision support systems: Some core concepts and questions

Year:

Session type:

Jeremy C Wyatt1
1Institute of Health Sciences, Leeds, UK



Computer based clinical decision support systems (CDSSs) utilising clinical prediction rules (CPRs) as part of referral for cancer

Year:

Session type:

Tom Fahey1
1HRB Centre for Primary Care Research, Dublin, Ireland



Practical implementation of cancer clinical decision support

Year:

Session type:

Willie Hamilton1
1University of Exeter Medical School, Exeter, UK



Introduction: Latest developments in radiotherapy for breast cancer

Year:

Session type:

Alastair M Thompson1
1Dundee Cancer Centre, UK

The metabolic autophagy pathway regulates the response to temozolomide in primary glioblastoma multiforme cells

Year:

Session type:

A Swampillai1,2, S Galavotti1,2, M Shaked-Rabi4, A McEvoy4, S Brandner4, S Short3
1UCL Cancer Institute, London, UK, 2Samantha Dickson Brain Cancer Unit, London, UK, 3Leeds Institute of Molecular Medicine, St James University Hospital, Leeds, UK, 4Department of Neuropathology, The Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK

Neutrophil to lymphocyte ratio is an independent prognostic factor for local/regional control in oropharyngeal squamous cell carcinoma

Year:

Session type:

Caroline Young1, Louise Murray1,3, Ebru Karakaya1, Helene Thygesen2, Robin Prestwich1
1St James's Institute of Oncology, Leeds, UK, 2Leeds Institute of Molecular Medicine, Leeds, UK, 3University of Leeds, Leeds, UK



From functional genomics to executable cancer biology

Year:

Session type:

Jasmin Fisher1
1Microsoft Research Cambridge, Cambridge, UK

FDG-PET parameters as predictors for outcome in non small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT)

Year:

Session type:

Mymoona Alzouebi1, Manil Subesinghe2, S Ramasamy1, Michael Snee1, Robert Turner1, Robert Stuart1, Kevin Franks1, Helene Thygesen3, Katy Clarke1
1St James's University Hospital, Leeds, UK, 2Leeds Teaching Hospital, Leeds, UK, 3University of Leeds, Leeds, UK



Transcriptional network control of normal and leukaemic blood stem/progenitor cells

Year:

Session type:

Bertie Gottgens1
1University of Cambridge, Cambridge, UK

Genomic and protein expression analysis reveals flap structure-specific endonuclease(FEN1) as a key prognostic, predictive and therapeutic target in breast and ovarian cancer

Year:

Session type:

Vivek Mohan1,4, Tarek MA Abdel-Fatah1, Roslin Russell2,3, Nada Albarakati4, David J Maloney5, Dorjbal Dorjsuren5, Oscar M Rueda2,3, Paul Moseley1, Hongmao Sun5, Abhik Mukherjee6, Devika Ravindra Agarwal7, Jennifer L Illuzzi8, Ajit Jadhav5, Anton Simeonov5, Graham Ball7, Stephen Chan1, Carlos Caldas2,3, Ian O Ellis6, David M Wilson III8, Srinivasan Madhusudan1,4
1Nottingham University Hospitals, Nottingham, UK, 2University of Cambridge, Cambridge, UK, 3Cancer Research UK Cambridge Research Institute, Cambridge, UK, 4University of Nottingham, Nottingham, UK, 5National Institutes of Health, Rockville, USA, 6School of Molecular Medical Sciences, University of Nottingham, Nottingham University Hospitals, Nottingham, UK, 7Nottingham Trent University, Nottingham, UK, 8National Institute on Aging, National Institutes of Health, Baltimore, USA



Computational models to predict and dissect mechanistically drug sensitivity in cancer

Year:

Session type:

Julio Saez-Rodriguez1
1European Bioinformatics Institute EMBL-EBI, Cambridge, UK

First UK cohort of prostate stereotactic body radiotherapy (SBRT): Acute toxicity and early PSA outcomes

Year:

Session type:

Alison Tree1, Peter Ostler2, Peter Hoskin2, Pittaya Dankulchai2,4, Vincent Khoo1,3, Nicholas van As1
1The Royal Marsden NHS Foundation Trust, London, UK, 2Mount Vernon Cancer Centre, Middlesex, UK, 3The Institute of Cancer Research, London, UK, 4Mahidol University, Bangkok, Thailand



Can computation help cure cancer?

Year:

Session type:

Jasmin Fisher1
1Microsoft Research Cambridge and University of Cambridge, Cambridge, UK

Isotoxic simultaneous integrated boost to dominant intra-prostatic lesions using stereotactic ablative radiotherapy and volumetric modulated arc therapy

Year:

Session type:

Louise Murray1,2, John Lilley1, Christopher Thompson1, Jonathan Sykes1, Kevin Franks1, David Sebag-Montefiore1,2, Vivian Cosgrove1, Ann Henry1
1St James's Institute of Oncology, Leeds, UK, 2University of Leeds, Leeds, UK



New methods for tumour functional imaging

Year:

Session type:

Kevin Brindle1
1University of Cambridge and Cancer Research UK Cambridge Institute, UK

Inhibition of ATM kinase preferentially abrogates glioblastoma cancer stem cell radioresistance

Year:

Session type:

Ross Carruthers1, Shafiq Ahmed1, Anthony Chalmers1
1University of Glasgow, Glasgow, UK

Simultaneous cone beam CT scanning during prostate radiotherapy produces clinically useful images

Year:

Session type:

Peter Dickinson1, Julie Stratford1, Chris Boylan1, Carl Rowbottom1, Ananya Choudhury1
1The Christie NHS Foundation Trust, Manchester, UK

Intensity Modulated Radiotherapy-Simultaneous Integrated Boost (IMRT-SIB) for treating the prostate and pelvic nodes in high risk localised and locally advanced prostate cancer: Initial experience of the first 100 patients

Year:

Session type:

Amarnath Challapalli1,2, Kirsty Blythe2, Melissa Tan2, Waqar Saleem2, Stephen Mangar2
1Imperial College, London, London, UK, 2Imperial College Healthcare NHS Trust, London, UK

Single-agent Bevacizumab used third line in recurrent high-grade glioma

Year:

Session type:

Nicola Goss1, Antonia Creak1, Juliet Brock1
1Sussex Cancer Centre, Brighton, UK

Clinical application of genetically modified iPS cell-based technologies, the appropriate model for the development of targeted therapeutics of regenerative medicine

Year:

Session type:

Mekhled Alzaza1
1RSM, London, UK

The use of biomarkers in predicting response to chemoradiation in locally advanced rectal cancer and prediction of complete response

Year:

Session type:

John McGrane1, Thomas Clarke2,3, David White2,3, Andrew Shaw4, Neil Smart3, Ian Daniels3,1, Melanie Osborne1
1Department of Oncology, Royal Devon & Exeter Hospital, Exeter, UK, 2University of Exeter Medical School, Exeter, UK, (HeSRU) Exeter Health Services Research Unit, 4College of Life and Environmental Sciences, University of Exeter, Exeter, UK

Tolerability of weekly cisplatin chemoradiation compared to standard dose cisplatin chemoradiation in locally advanced head and neck patients: A single institute experience

Year:

Session type:

Cheng Lee Chaw1, Lesley Taylor1, Paddy Niblock1, Richard Casasola1
1Ninewells Hospital and Medical School, Dundee, UK

A study of methylation status of hMLH1 gene in colorectal cancer patients of Kashmir

Year:

Session type:

Showkat Ahmad Bhat1, Mashooq Ahmad Dar2, Manzoor ur Rahman Mir1, Ishraq Hussain1, Ahmad Arif1, Hilal Ahmad Wani1
1(F.V. Sc & AH) Division of veterinary Biochemistry of Veterinary Sciences & Animal Husbandry, 2Department of Cinical Biochemistry, University of Kashmir, Jammu & Kashmir, India, 3Department of Biochemistry, Govt. Medical College Srinagar, Jammu & Kashmir, India

Neoadjuvant treatment of liver metastases in metastatic colorectal cancer

Year:

Session type:

Iain Phillips1, Emma Bodenham1, Andrew Webb1, Ben O'Leary1
1Sussex Cancer Centre, Brighton, UK

Adjuvant management of stage 1 classical seminoma

Year:

Session type:

Kirsty MacLennan1, Alastair Law1, Duncan McLaren1, Jahangeer Malik1
1Edinburgh Cancer Centre, Edinburgh, UK

Supporting family carers: International evidence

Year:

Session type:

Gunn Grande1
1University of Manchester, Manchester, UK

Cancer predisposition genes: Past glories, future imperatives

Year:

Session type:

Nazneen Rahman1
1The Institute of Cancer Research and The Royal Marsden Hospital Foundation Trust, London, UK

Supporting family carers: Identifying differences between urban and rural care at the end of life in Canada 

Year:

Session type:

Kevin Brazil1
1Queen's University Belfast, Northern Ireland, UK

Supporting family carers: Outcome of caregiving in nationwide register-based Scandinavian studies

Year:

Session type:

Mai-Britt Guldin1
1Research Unit for General Practice, Aarhus, Denmark

Using next-generation sequencing to transform clinical practice

Year:

Session type:

Nazneen Rahman1
1The Institute of Cancer Research, London, UK

The Mainstreaming Cancer Genetics Programme: Integrating genetic testing into routine clinical practice

Year:

Session type:

Clare Turnbull1
1The Institute of Cancer Research, London, UK

The Heidelberg Center for Personalized Oncology

Year:

Session type:

Christof von Kalle1
1National Center of Tumor Diseases, Heidelberg and German Cancer Research Center (DKFZ), Germany

Depression in advanced cancer – the orphan symptom?

Year:

Session type:

Mari Lloyd-Williams1
1University of Liverpool, Liverpool, UK

Introduction: Clinical application of translational research in breast cancer

Year:

Session type:

John Yarnold1
1The Institute of Cancer Research, London, UK